Publication:
Elevated levels of F2-alpha isoprostane in cystic fibrosis
Elevated levels of F2-alpha isoprostane in cystic fibrosis
dc.contributor.author | Collins, CE | en_US |
dc.contributor.author | Quaggiotto, P | en_US |
dc.contributor.author | O’Louglin, V | en_US |
dc.contributor.author | Henry, RL | en_US |
dc.contributor.author | Garg, ML | en_US |
dc.date.accessioned | 2021-11-25T12:49:22Z | |
dc.date.available | 2021-11-25T12:49:22Z | |
dc.date.issued | 1999 | en_US |
dc.identifier.uri | http://hdl.handle.net/1959.4/11256 | |
dc.language | English | |
dc.language.iso | EN | en_US |
dc.rights | CC BY-NC-ND 3.0 | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/au/ | en_US |
dc.source | Legacy MARC | en_US |
dc.title | Elevated levels of F2-alpha isoprostane in cystic fibrosis | en_US |
dc.type | Journal Article | en |
dcterms.accessRights | metadata only access | |
dspace.entity.type | Publication | en_US |
unsw.accessRights.uri | http://purl.org/coar/access_right/c_14cb | |
unsw.identifier.doiPublisher | http://dx.doi.org/doi:10.1007/s11745-999-0397-1 | en_US |
unsw.relation.faculty | Other UNSW | |
unsw.relation.ispartofjournal | Lipids | en_US |
unsw.relation.ispartofpagefrompageto | 551-556 | en_US |
unsw.relation.ispartofvolume | 34 | en_US |
unsw.relation.originalPublicationAffiliation | Collins, CE | en_US |
unsw.relation.originalPublicationAffiliation | Quaggiotto, P | en_US |
unsw.relation.originalPublicationAffiliation | O’Louglin, V | en_US |
unsw.relation.originalPublicationAffiliation | Henry, RL, UNSW | en_US |
unsw.relation.originalPublicationAffiliation | Garg, ML | en_US |